SFX by Ex Libris Inc.

Title:	Therapeutic antibody targeting of individual Notch receptors
Source:	Nature [0028-0836] Wu, Y yr:2010

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Dirks, Sheila K B. "Identification of human brain tumour initiating cells." Nature 432.7015 (2004): 396-401.
description	2.	Thurston, G. "The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth." Nature reviews. Cancer 7.5 (2007): 327-331.
description	3.	Zhou, John S. "Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer." Cancer cell 10.1 (2006): 39-50.
description	4.	Patrick A, Y. "Critical role of notch signaling in osteosarcoma invasion and metastasis." Clinical cancer research 14.10 (2008): 2962-9.
description	5.	Mentlein, R. "Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides." Regulatory peptides 85.1 (2000): 9-24.
description	6.	Singh, Sheila K K. "Identification of a cancer stem cell in human brain tumors." Cancer research 63.18 (2003): 5821-8.
description	7.	O'Brien, Steven A. "A human colon cancer cell capable of initiating tumour growth in immunodeficient mice." Nature 445.7123 (2006): 106-10.
description	8.	Lombardi, L. "Identification and expansion of human colon-cancer-initiating cells." Nature 445.7123 (2006): 111-5.
description	9.	Al Hajj, M. "Prospective identification of tumorigenic breast cancer cells." Proceedings of the National Academy of Sciences of the United States of America 100.7 (2003): 3983-3988.
description	10.	Phng, L. "Angiogenesis: A Team Effort Coordinated by Notch." Developmental cell 16.2 (2009): 196-208.
description	11.	Vescovi, A. "Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma." Cancer research 64.19 (2004): 7011-21.
description	12.	Noguera-Troise, I. "Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis." Nature 444.7122 (2006): 1032-1037.
description	13.	Ridgway, J. "Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis." Nature 444.7122 (2007): 1083-7.
description	14.	Ferrara, N. "Angiogenesis as a therapeutic target." Nature 438.7070 (2005): 967-974.
description	15.	Devika, P. "Computational understanding of selective MMP inhibitors in COPD." International journal of pharmaceutical sciences and research 3.12 (2012): 4959-.
description	16.	FOLKMAN, J. "ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE." Nature medicine 1.1 (1995): 27-31.
description	17.	Morimoto, C. "The structure and function of CD26 in the T-cell immune response." Immunological reviews 161.1 (1998): 55-70.
description	18.	De Meester, I. "CD26, let it cut or cut it down." Immunology today 20.8 (1999): 367-75.
description	19.	Roma, J. "Notch Pathway Inhibition Significantly Reduces Rhabdomyosarcoma Invasiveness and Mobility In Vitro." Clinical cancer research 17.3 (2011): 505-513.
description	20.	Sorensen, Poul H B J. "Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma." The oncologist 15.6 (2010): 627-635.